CSIMarket
 
Invitae Corporation  (NYSE: NVTA)
    Sector  Healthcare    Industry Medical Laboratories
   Industry Medical Laboratories
   Sector  Healthcare
 
Price: $0.0000 $0.00 %
Day's High: 0.00 Week Perf:
Day's Low: $ 0.00 30 Day Perf:
Volume (M): 0 52 Wk High: $ 0.00
Volume (M$): $ 0 52 Wk Avg: $0.00
Open: $0.00 52 Wk Low: $0.00



 Market Capitalization (Millions $) -
 Shares Outstanding (Millions) 276
 Employees 1,200
 Revenues (TTM) (Millions $) 482
 Net Income (TTM) (Millions $) -1,441
 Cash Flow (TTM) (Millions $) -59
 Capital Exp. (TTM) (Millions $) 10

Business Description


Invitae Corporation is a leading medical genetics company that provides genomic information to patients and healthcare providers through diagnostic tests and proactive research. The company was founded in 2010 and is headquartered in San Francisco, California.

Invitae's mission is to improve healthcare by making genetic testing accessible and affordable to everyone. The company's platform offers a comprehensive suite of tests that covers a wide range of genetic conditions, from rare diseases to complex disorders. Its offerings include genetic testing for cancer, neurology, cardiology, pediatrics, and reproductive health.

Invitae's diagnostic tests are performed using state-of-the-art technologies and are designed to deliver accurate and reliable results. The company has a team of genetic counselors and medical professionals who provide pre- and post-test counseling to patients and healthcare providers. Invitae's genetic testing service is also supported by a proprietary software platform, which facilitates the interpretation and reporting of test results.

In addition to its diagnostic testing services, Invitae is also actively involved in genomic research. The company collaborates with academic institutions and research organizations to gather and analyze genetic data, with the goal of advancing the understanding of genetic diseases and developing new treatments.

Invitae's business model is built on a pay-per-test approach, which allows healthcare providers and patients to order tests as needed. This approach has enabled the company to offer affordable testing options and drive adoption of genetic testing in the healthcare market.

Since its founding, Invitae has rapidly gained traction in the medical genetics field, with a growing customer base and revenue. The company has also expanded its operations to include international markets, with an established presence in Canada, Australia, and Europe.

In summary, Invitae Corporation is a leading medical genetics company that provides comprehensive genetic testing services to patients and healthcare providers. Its mission is to improve healthcare by making genetic testing accessible and affordable, and its platform offers a wide range of diagnostic tests and genomic research solutions. With its innovative business model and commitment to advancing genetic science, Invitae is poised to continue leading the way in the medical genetics industry.


   Company Address: 1400 16th Street San Francisco 94103 CA
   Company Phone Number: 374-7782   Stock Exchange / Ticker: NYSE NVTA


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
CDNA        0.18% 
EXAS        0.29% 
FLGT        3.08% 
FTRE   -6.44%    
GH   -2.36%    
NTRA        0.06% 
• View Complete Report
   





Fundamental Analysis

Valuation Current
Price to Earnings PE Ratio (TTM) -
Price to Earnings PE Ratio (Expected) -
Price to Sales (TTM) -
Price to Sales (Expected) -
Price to Book -
PEG (TTM) -

Financial Strength Current
Quick Ratio 1.61
Working Capital Ratio 2.39
Leverage Ratio (MRQ) -
Total Debt to Equity -
Interest Coverage (TTM) -
Debt Coverage (TTM) -

Per Share Current
Earnings (TTM) -5.39 $
Revenues (TTM) 1.75 $
Cash Flow (TTM) -
Cash 0.92 $
Book Value -
Dividend (TTM) 0 $

Efficiency Current
Revenue per Employee (TTM) 401,319
Net Income per Employee (TTM) -1,200,515
Receivable Turnover Ratio (TTM) 5.51
Inventory Turnover Ratio (TTM) 15.28
Asset Turnover Ratio (TTM) 0.36

Profitability Ratios Current
Gross Margin (MRQ) 32.21 %
Operating Margin (MRQ) -808.46 %
Net Margin (MRQ) -777.05 %
Net Cash Flow Margin (MRQ) -53.74 %
Effective Tax Rate (TTM) -

Management Effectiveness Current
Return On Assets (TTM) -
Return On Investment (TTM) -
Return On Equity (TTM) -
Dividend Yield -
Pay out Ratio (TTM) -






Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.